Topics & Abstracts

2020 Main Presentations:

GOLD Obstetrics 2020 offers 10.5 hours of education for the main conference, with the option to extend your conference experience with 3 highly informative Add-on Lecture Packages: Breech Birth, Mental Health in the Perinatal Period and Breastfeeding Medicine: Advancing Your Level of Care.

We invite you to learn more about the 2020 topics and abstracts below.

Please note that we are currently adding more speakers & topics.
  • 12 Steps to Safe and Respectful MotherBaby-Family Maternity Care
    by Andre Lalonde, MD FRCSC MSc 60 mins

    The International MotherBaby Childbirth Organization (IMBCO) and the International Federation of Gynecology and Obstetrics (FIGO) joined forces developing a single global initiative to provide guidance and support for safe and respectful maternity care. This work was built upon their previous initiatives and incorporates the most recent evidence and insights relating to quality maternal, newborn and child health provision. It also reflects much of the work being carried out by many organizations involved in maternal and newborn health throughout the world.

    This initiative, The International Childbirth Initiative (ICI): 12 Steps to Safe and Respectful MotherBaby-Family Maternity Care was launched as a FIGO Presidential Initiative for 2018-2021 during the World Congress in Brazil in 2018 in a special side event with presentations from key partner organizations. ICI provides clear steps for the implementation of evidence-based maternity care worldwide, acknowledging the interaction between the MotherBaby dyad and Family environment as well as their interactions with health providers-and-systems. It provides a web-based platform of support for implementation and a self-initiated and self-reflective quality improvement cycle.


    Objective 1: Describe the model and principles for the International Childbirth Initiative (ICI);

    Objective 2: Discuss disrespectful care in labour and delivery;

    Objective 3: List the 12 steps and indicators in the International Childbirth Initiative

    Pre-Recorded Presentation
  • Creating Wellness In Pregnancy: How To Affect The Best Outcome
    by Angela R. Jones, MD, FACOG 60 mins

    “Wellness” is defined as an active process of becoming aware of and making choices towards a healthy and fulfilling life. As our understanding of epigenetics grows, it is obvious that pregnancy is a time when we need to be supporting our clients to take an active role in creating wellness in their lives. This presentation will review the pregnancy experience from start to finish, including preconceptional counseling; what it entails and why it is important. Review obstetric care from trimester to trimester with a focus on the key areas where opportunities for creating wellness exist. Both routine obstetric visits and high-risk pregnancies will be examined. Learn how to improve outcomes by engaging your clients in actively taking responsibility for improving their health and wellbeing through things such as healthy eating, exercise and self-care.


    Coming Soon!

    Pre-Recorded Presentation
  • How The Principles of Palliative Medicine Can Improve Your Obstetrics Practice
    by Nathan Riley, MD 75 mins

    Principles of palliative medicine can benefit all medical disciplines, but none more so than obstetrics and gynecology. I will be discussing fundamentals of symptom management and helping to illustrate how patient-centered medical decision-making is of critical importance to birth work and the support of women in healthcare. Learn more about the principles of palliative medicine, a palliative approach to birth planning, a framework for breaking bad news and the importance of holding space.


    Objective 1: Explain management of pain, nausea, constipation, and anxiety.;

    Objective 2: Demonstrate palliative approach to birth planning;

    Objective 3: Describe the importance of holding space in scary times;

    Objective 4: Utilize a framework for breaking bad news.

  • Imitators Of Preeclampsia: Manifestations Of Endothelial Dysfunction In Context Of Hypertensive Disorders Of Pregnancy
    by Jeff M. Denney, MD, MS, FACOG 60 mins

    Background: Simply stated, preeclampsia is new-onset hypertension with proteinuria during gestation. However, preeclampsia is complex, virtually affects every organ and is often confused with other entities--imitators of preeclampsia.

    Methods: My aim is to provide clinicians with a working framework. Such framework is key in identifying underlying disease processes that mimic or predispose patients toward developing hypertensive disorders and evolving manifestations (eg, renal failure in SLE).

    Results: Select data will be reviewed to tie in insights with numerous portals and pathophysiologic processes that lead to pre-eclampsia, hypertensive disorders or pregnancy and the so-called imitators of preeclampsia (eg, AFLP, HELLP, SLE, TTP-HUS). Underlying processes or preexisting chronic diseases all lead to an assortment of physiologic dysfunctions affecting uterus and kidney with or without additional organ involvement.

    Conclusion: Many disease processes predispose toward preeclampsia and/or imitators of preeclampsia. Regardless of background and ultimate pathway, over-arching principles are shared.


    Objective 1: Describe the classification schema for both hypertension and hypertensive d/o’s of pregnancy;

    Objective 2: Explain guiding pathophysiologic principles and the pathways/manifestations arising in each;

    Objective 3: List imitators of preeclampsia.

    Pre-Recorded Presentation
  • Management Of Breast Cancer During Pregnancy
    by Fedro Alessandro Peccatori, MD PhD 60 mins

    Breast cancer is the most common cancer diagnosed during pregnancy. The incidence of breast cancer in pregnancy is expected to rise since women tend to postpone childbearing and the incidence of breast cancer increases with age. The management of this situation is a clinical challenge for all the involved health care providers and relies on multidisciplinarity and shared decision making with the patient and her partner. Diagnostic imaging and staging may be safely performed during pregnancy, favoring methods without ionizing radiations (e.g. ultrasound and MRI). Surgery is possible throughout the whole pregnancy. Chemotherapy can be safely administered to the mother starting from the second trimester, without fetal impairment. Data about the impact of chemotherapy on subsequent child development are reassuring, but long term follow-up is needed.

    In this lecture we will present an overview of the current knowledge about the biology, prognosis and treatment options of breast cancer during pregnancy, highlighting results of recent research on neonatal outcome and recommendations concerning prenatal care!


    Objective 1: Understanding epidemiology and biology of breast cancer during pregnancy (20 min) An overview of recent data will be presented, outlining epidemiological and biological peculiarity of breast cancer during pregnancy;

    Objective 2: Understanding treatment modalities of breast cancer during pregnancy (20 min) Surgery, chemotherapy and supportive care of breast cancer during pregnancy will be presented;

    Objective 3: Understanding the impact of chemotherapy on fetal/neonatal development (20 min) Data on placental toxicity obstetrical management and neonatal development will be presented

    Pre-Recorded Presentation
  • Management of Medical Disorders On The Labour Ward
    by Catherine Nelson-Piercy, MA,FRCP, FRCOG 60 mins

    Women are delaying pregnancy until older ages and fertility treatments mean that age is no longer a barrier to reproduction. Therefore women are more likely to have co-morbidities such as diabetes, hypertension, obesity and other chronic medical problems. Medical problems represent a more common cause of death in pregnancy and the puerperium than direct obstetric conditions. The most common cause of death in pregnancy in the developed world is cardiac disease. This lecture will discuss the most serious and most common presentations of medical problems on the labour ward and highlight important aspects of management. Effective management requires team work particularly with physicians, midwives and obstetric anaesthetists.

    Causes of breathlessness, chest pain, headache and seizures will be covered and the management of asthma, pneumonia, acute coronary syndrome, pulmonary oedema, aortic dissection, pulmonary embolism discussed.


    Objective 1: List the causes of chest pain in pregnancy;

    Objective 2: List the causes of breathlessness in pregnancy;

    Objective 3: Describe the diagnosis and management of pulmonary embolism in pregnancy;

    Objective 4: Discuss the differential diagnosis of headache in pregnancy.

    Pre-Recorded Presentation
  • Placenta Accreta Spectrum: The Rise Of An Iatrogenic Killer
    by Sally Collins, MD PhD 60 mins

    Placenta accreta spectrum (PAS) is a rare iatrogenic pregnancy complication with an increasing incidence worldwide. PAS can cause serious maternal morbidity and even mortality at delivery. The aim of this presentation is to discuss the pathophysiology of the condition including: an explanation of the risk factors and how they lead to developing different severities, current policies for screening and the evidence behind the recommended management strategies.


    Objective 1: Explain management of pain, nausea, constipation, and anxiety;

    Objective 2: Demonstrate palliative approach to birth planning;

    Objective 3: Describe the importance of holding space in scary times;br>
    Objective 4: Utilize a framework for breaking bad news.

    Pre-Recorded Presentation
  • The Evidence and Future of Intrapartum Fetal Monitoring
    by Diogo Ayres-de-Campos, MD, PhD 60 mins

    Continuous cardiotocography (CTG) remain widely used for intrapartum fetal monitoring, despite the conflicting evidence regarding the benefits of such approach when compared with intermittent auscultation. Existing evidence on this topic will be re-analysed, together with the need to improve specific aspects of the CTG technology in order to achieve the best outcomes. Central fetal monitoring and computer analysis of CTGs is also widely disseminated in industrialised countries. Existing systems will be compared with an emphasis on system characteristics and demonstrated benefit.

    Pre-Recorded Presentation
  • Twins In 2020 - All You Need To Know
    by Jon Barrett, MBBch, MD, FRCOG, FRCSC 60 mins

    This Presentation will prevent an update on the latest incidence, etiology and pathophysiology of a twin pregnancy. We will discuss ultrasound imaging and the importance of chorionicity's determination and then follow a typical patient through pregnancy with key points for the diagnosis and treatment of complications. Special mention will be made of the latest evidence of preterm birth prevention in twins and thereafter will talk about twin birth and particularly the twin birth study.


    Objective 1: Describe the importance of chorionicity determination in pregnancy;

    Objective 2: Discuss the latest evidence of preterm prediction and prevention in twins;

    Objective 3: Discuss the latest evidence behind the conduct of a safe twin delivery

    Pre-Recorded Presentation
  • Why is it so Hard to Align Clinical Practice with the Evidence About Cardiotocography Monitoring?
    by Kirsten Small, PhD FRANZCOG 75 mins

    Quality research evidence demonstrates that intrapartum Cardiotocography monitoring in either low or high-risk populations fails to improve perinatal outcomes but drives harm by increasing the surgical birth rate. This evidence is not new, and obstetrics claims to be an evidence-based profession, yet there has been little interest or success in reducing the use of intrapartum CTG monitoring. This presentation draws on doctoral research which makes visible why it is so hard to align practice with evidence and challenges clinicians and leaders in our profession to rethink intrapartum fetal heart rate monitoring.


    1. Summarise evidence pertaining to intrapartum CTG monitoring

    2. Identify systemic structures which support and enable the ongoing inappropriate use of intrapartum CTG monitoring

    3. Identify local opportunities to influence clinical practice relating to the use of intrapartum CTG monitoring